Suno opens Speech beta for spoken audio with generated music

October 2, 2026

Suno opened its Speech beta to everyone on October 1 after a month of testing with a smaller user group. The feature generates spoken audio with original background music as a cohesive track.

Users enter an idea, poem or other text and describe the voice and musical style they want. Speech is built into Suno rather than presented as a separate editing application.

Creative uses and beta limits

The company describes potential uses such as dramatic readings, meditations, pep talks and bedtime stories. Those examples illustrate the intended creative scope; they are not guarantees about the quality of a particular output.

Suno cautions that the beta can produce inconsistent accents and exaggerated pauses. Its launch announcement does not detail Speech-specific pricing or commercial-use rights, so those terms should be checked separately before using generated audio in a paid project.

Source

Suno product announcement.

Feature image: AI-generated editorial illustration for Guava Insights. Conceptual artwork, not a product photograph or depiction of an actual facility or legal proceeding.

Topics:
Read next
October 23, 2026

OpenAI Reportedly Seeks $30B at About $1.4T Valuation

Reports from early October say OpenAI is seeking at least $30 billion at about a $1.4 trillion pre-money valuation, with UAE funds up to $10 billion and BlackRock in talks, and an IPO pushed to at least 2027. Nothing is confirmed.
October 23, 2026

Walmart Opens to AI Shopping Agents While Amazon Blocks Them

On October 21, Walmart announced an MCP server that lets approved AI agents search inventory and buy for shoppers at Walmart and Sam’s Club, with spending limits and per-agent profiles. Amazon, meanwhile, is blocking agent purchases.
October 23, 2026

Microsoft MAI-DxO in Science: 83% on Hard Cases, With Caveats

A peer-reviewed Science study reports Microsoft’s MAI-DxO diagnosing 83.2% of 304 complex NEJM cases versus 36.1% for generalist physicians. The setup matters: text-only cases, no exams, no imaging, no clinical deployment yet.